1. Most Discussed
  2. Gainers & Losers
PC1 0.0¢

to the loyal followers

  1. GAOXO

    70 Posts.

    For those who follow ACU you should know what the article (thx to oze) means :) Also, don't forget that the clinical trials starts in october.

    Australian researchers make cancer breakthrough

    Source: MELBOURNE, Sept 19 AAP

    Published: Friday September 19 2003, 1:45 PM

    Australian researchers may have found what makes cancer treatments work or fail, discovering that two proteins are critical for success.

    The research, which has so far only been conducted on genetically engineered mice, shows the proteins Puma and Noxa must be present in the body to enable chemo or radio therapy or drugs to kill cancer cells.

    Team leader Dr Andreas Strasser from the Walter and Eliza Hall Institute in Melbourne said earlier studies had shown a protein called p53 was responsible for killing cells.

    But scientists were mystified as to how the process worked.
    The Melbourne team now believed cancer treatments were successful when p53 activated the proteins Puma or Noxa.

    "We decided to test Puma and Noxa, we thought they might be the critical killer proteins ... that generate cell suicide," Dr Andreas said.

    "The drugs depend on p53 to activate Noxa and Puma or both.

    "The basic research clearly identified two killer proteins as being the ones that do the job of killing (cancer) cells after treatment with chemotherapeutic drugs or radiation."

    The catch is that only half of all human cancers have been found to have p53.

    "That is a major reason why therapies vary in effectiveness between different types of cancer," Dr Andreas said.

    He said the work seemed to indicate that people who responded badly to cancer treatments had a deficiency in p53 or an inability to activate Puma or Noxa proteins.

    The next step is to test mice which are missing one or the other of the proteins to see whether they have an abnormal predisposition to developing cancer.

    Dr Strasser said the work was the "hottest area of medical research" at the moment and the Australian team had beaten researchers in Europe, the United States and Japan to the punch.

    The research was published yesterday in the prestigious journal Science.

    By Heather Gallagher

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.